A case of fatal systemic toxoplasmosis in a cat being treated with cyclosporin A for feline atopy

Veterinary Dermatology

Volumn 15, Issue 3, 2004, Pages 194-198

  Last, Robert D ^a   Suzuki, Yasuhiro ^b   Manning, Thomas ^b   Lindsay, David ^b   Galipeau, Laura ^c   Whitbread, Trevor J ^d  

^a Vetdiagnostix Veterinary Pathology Services   (South Africa)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^c Brookmead Veterinary Surgery   (United Kingdom)

^d Abbey Veterinary Services   (United Kingdom)

Author keywords

Cyclosporin A; Feline atopy; Immunomodulatory therapy; Toxoplasma gondii; Toxoplasmosis

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; CYCLOSPORIN A; GLUCOCORTICOID; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT;

ACUTE DISEASE; ALLERGY; ANAMNESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATOPY; CAT DISEASE; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG MECHANISM; EOSINOPHILIA; FATALITY; GRANULOMA; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOPATHOLOGY; LIVER DISEASE; LOW DRUG DOSE; LYMPHOCYTE FUNCTION; MALE; NONHUMAN; PANCREAS DISEASE; PARASITOSIS; PRURITUS; RISK FACTOR; SKIN DISEASE; STAINING; SYSTEMIC DISEASE; T LYMPHOCYTE; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; CAT DISEASES; CATS; CYCLOSPORINE; DERMATITIS, ATOPIC; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; IMMUNOCOMPROMISED HOST; MALE; PARASITEMIA; TOXOPLASMOSIS, ANIMAL;

ANIMALIA; FELIDAE; FELIS CATUS; TOXOPLASMA GONDII;

EID: 3242661930     PISSN: 09594493     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2004.00371.x     Document Type: Article

References (32)

1. Roosje PJ, Thepen TH, Rutten VPMG et al. Feline atopic dermatitis: a review (Abstract). Veterinary Dermatology 2000; 11 (Suppl. 1): 12.
2. Foster A. Diagnosing and treating feline atopy. Veterinary Medicine 2002; 97: 226-40.
3. Power H. A practitioner's approach to allergic skin disease in cats. Proceedings of the 17th Annual Meeting of the European Society of Veterinary Dermatology/European College of Veterinary Dermatology. Copenhagen, 2001: 79-86.
4. Prelaud P, Gilbert S. Atopic dermatitis. In: A Practical Guide to Feline Dermatology. France: Merial, 1999.
5. Scott DW, Miller WH, Griffin CE, eds. Small Animal Dermatology, 6th edn. Philadelphia: WB. Saunders, 2001; 601-8.
6. Wassom DL, Grieve RB. In vitro measurement of canine and feline IgE. A review of Fc epsilon R1 alpha-based assays for detection of allergen-reactive IgE. Veterinary Dermatology 1998; 9: 173-8.
7. Guaguere E. Cyclosporin A a new drug in the field of veterinary dermatology. In: Proceedings of the Spring Meeting of the British Veterinary Dermatology Study Group 2001: 23-34.
8. Center SA. Acute hepatic injury: hepatic necrosis and fulminant hepatic failure. In: Gulford WG, Center SA, Strombeck DR. et al. eds. Small Animal Gastroenterology, 3rd edn. Philadelphia: WB. Saunders, 1996: 683.
9. Jones TJ, Hunt RD, King NW, eds. Veterinary Pathology, 6th edn. Baltimore: Williams & Wilkins, 1996: 555-61.
10. Lappin MR. Protozoal and miscellaneous infections. In: Ettinger SJ, Feldman EC. eds. Textbook of Veterinary Internal Medicine, 5th edn. Philadelphia: W.B. Saunders, 2000: 410-13.
11. Barker IK, Van Dreumel AA, Palmer N. The alimentary system. In: Jubb KVF, Kennedy PC, Palmer N. eds. Pathology of Domestic Animals, 4th edn. San Dieago: Academic Press, 1993: 308-10.
12. Bowman DD, Hendrix CM, Lindsay DS et al. Feline Clinical Parasitology. Ames: Iowa State University Press, 469.
13. Summers BA, Cummings JF, de Lahunta A, ed. Veterinary Neuropathology. St. Louis, MO: Mosby, 1995: 163-9 .
14. Dubey JP, Mattix ME, Lipscomb TP. Lesions of neonatally induced toxoplasmosis in cats. Veterinary Pathology 1996; 33: 290-5.
15. Lappin MR, Dawe DL, Lindl PA et al. The effect of glucocorticoid administration on oocyst shedding, serology and cell mediated immune responses of cats with recent or chronic toxoplasmosis. Journal of the American Animal Hospital Association 1991; 27: 625-32.
16. Lappin MR, Gasper PW, Rose BJ et al. Effect of primary phase feline immunodeficiency virus on cats with chronic toxoplasmosis. Veterinary Immunology and Immunopathology 1992; 35: 121-31.
17. Lappin MR, Marks A, Greene CE et al. Effect of feline immunodeficiency virus on Toxoplasma gondii-specific humoral and cell mediated immune responses of cats with serological evidence of toxoplasmosis. Journal of Veterinary International Medicine 1993; 7: 95-100.
18. Lappin MR, George JW, Pedersen NC et al. Primary and secondary Toxoplasma gondii infections in normal and feline immunodeficiency virus infected cats. Journal of Parasitology 1996; 82: 733-42.
19. Lin DS, Bowman DD. Macrophage functions in cats experimentally infected with feline immunodeficiency virus and Toxoplasma gondii. Veterinary Immunology and Immunopathology 1992; 33: 69-78.
20. Lin DS, Bowman DD, Jacobson RH. Immunological changes in cats with concurrent Toxoplasma gondii and feline immunodeficiency virus infections. Journal of Clinical Microbiology 1992; 30: 17-24.
21. Patton S, Legendre AM, McGavin MD et al. Concurrent infection with Toxoplasma gondii and feline leukemia virus. Journal of Veterinary International Medicine 1991; 5: 199-201.
22. Lindsay DH, Dubey JP. Immunohistochemical diagnosis of Neospora caninum in tissue sections. American Journal of Veterinary Research 1989; 50: 1981-3.
23. Dubey JP, Carpenter JL. Histologically confirmed clinical toxoplasmosis in cats: 100 cases (1952-90). Journal of the American Veterinary Medical Association 1993; 203: 1556-66.
24. Bernsteen L, Gregory CR, Aronson LR et al. Acute toxoplasmosis following renal transplantation in three cats and a dog. Journal of the American Veterinary Medical Association 1999; 215: 1123-6.
25. Dubey JP, Frenkel JK. Immunity to feline toxoplasmosis: modification by administration of corticosteroids. Veterinary Pathology 1974; 11: 350-79.
26. Hagiwara T, Katsube Y, Muto T et al. Experimental feline toxoplasmosis. Japanese Journal of Veterinary Science 1981; 43: 329-36.
27. Chappell LH, Wastling JM. Cyclosporin A. Antiparasitic drug, modulator of the host parasite relationship and immunosuppressant. Parasitology 1992; 105 (Suppl.): S25-40.
28. Garon CLG, Scott MA, Selting KA et al. Idiopathic thrombocytopaenic purpura in a cat. Journal of the American Animal Hospital Association 1999; 35: 464-70.
29. Silverman JA, Hayes ML, Luft BJ et al. Characterization of anti-toxoplasma activity of SDZ 215-918, a cyclosporin derivative lacking immunosuppressive and peptidyl-prolyl-isomerases inhibiting activity: possible role of a P glycoprotein in toxoplasma physiology. Antimicrobial Agents and Chemotherapy 1997; 41 (9): 1859-66.
30. Sumyuen MH, Gavin YJ, Derouin F. Effect of immunosuppresive drug regimens on acute and chronic murine toxoplasmosis. Parasitology Research 1996; 82: 681-6.
31. Groves MG, Harrington KS, Taboada J. Frequently asked questions about soonoses. In: Ettinger SJ, Feldman EC. eds. Textbook of Veterinary Internal Medicine, 5th edn. Philadelphia: WB. Saunders, 2000: 388-9.
32. DeFeo ML, Dubey JP, Mather TN et al. Epidemiologic investigation of seroprevalence of antibodies to Toxoplasma gondii in cats and rodents. American Journal of Veterinary Research 2002; 63: 1714-17.